Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
CAR T-Cell Therapy: early-phase trial registry
4 of 4 indexed CAR T-Cell Therapy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 4 currently recruiting · #4,115 of 28,707 conditions by registered trial count
CAR T-Cell Therapy: 4 US clinical trials tracked, 4 recruiting.
CAR T-Cell Therapy is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Kansas Medical Center, running 1 of these trials.
Enrollment posture brief
Registry condition car-t-cell-therapy
OPEN 4 | RECR 100% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
CAR T-Cell Therapy lists 4 open slots (100% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for CAR T-Cell Therapy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
CAR T-Cell Therapy is recruiting above its size-band peers.
4 of 4 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Nutrition OUtReach In Systems of Healthcare
University of Kansas Medical Center
NCT06802406
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
Duke University
NCT06575712
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
University of Arizona
NCT06643221
Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy
University of California, San Diego
NCT07075523
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on CAR T-Cell Therapy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on CAR T-Cell Therapy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this CAR T-Cell Therapy page
4 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 CAR T-Cell Therapy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Kansas Medical Center sponsors the most CAR T-Cell Therapy trials on record, review their full trial history before evaluating a specific study. See University of Kansas Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This CAR T-Cell Therapy condition card totals 4 registered trials; most-linked intervention Usual Care Plus (UC+); top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.